FDG - PET, one of
the only molecular imaging techniques routinely used in oncology, employs a glucose - like probe, FDG, with a radioactive isotope of fluorine attached as a beacon.
Not exact matches
These so - called structured beams not
only can tell scientists a lot about the physics of light, they have a wide range of applications from super-resolution
imaging to
molecular manipulation and communications.
A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance
imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (
imaging (MRI) agents that bind to the protein in not
only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and
Molecular Imaging (
Imaging (SNMMI).
Not
only does the technology have its roots in the U-M Department of Radiology's Center for
Molecular Imaging, it was also tested thoroughly by a separate team of U-M Health System lung - imaging e
Imaging, it was also tested thoroughly by a separate team of U-M Health System lung -
imaging e
imaging experts.
Patrick McConville, Ph.D., is chief operating officer, chief scientific officer, and a co-founder of
Molecular Imaging Inc., the only contract research organization (CRO) dedicated to in vivo preclinical i
Imaging Inc., the
only contract research organization (CRO) dedicated to in vivo preclinical
imagingimaging.
Baltimore, Md. (Embargoed until 12:30 pm EDT on Monday, June 8)-- A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance
imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (
imaging (MRI) agents that bind to the protein in not
only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 Annual Meeting of the Society of Nuclear Medicine and
Molecular Imaging (
Imaging (SNMMI).